New innovations have created massive volumes of never-before-seen data in the Pharmaceutical industry: From smart devices to smart pills and even smart bottles that track usage, this wealth of new data represents immense opportunity. Yet organizations bound by the size and speed limitations of their legacy systems struggle to keep pace.
With a compact and cost-efficient platform, SQream fills the prescription for pharmaceuticals looking to rapidly ingest, analyze, explore, and derive value from their massive influx of data. Researchers can run ad-hoc queries to explore their data on more dimensions. With accelerated analytics feeding the drug-development pipeline, new medications, treatments, and devices can emerge with maximal safety and efficiency.
Compare thousands of DNA samples instead of just a handful to identify genetic markers over a large population. SQream cuts years off medical research.
Train your predictive models with massive molecular and clinical data to uncover new patterns and identify potential drug candidates and precision medicines.
Correlate data from more sources to improve the criteria for selecting patients, target specific populations, and run more effective clinical trials.
“SQream is helping us to cut years of cancer research on large genomic datasets.”
Prof. Gideon Rechavi, Head of Cancer Research at Sheba Medical Center